Publications by authors named "Denise Treue"

18 Publications

  • Page 1 of 1

TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.

J Pathol Clin Res 2021 01 12;7(1):3-9. Epub 2020 Nov 12.

Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

View Article and Find Full Text PDF
January 2021

Multiclass cancer classification in fresh frozen and formalin-fixed paraffin-embedded tissue by DigiWest multiplex protein analysis.

Lab Invest 2020 10 29;100(10):1288-1299. Epub 2020 Jun 29.

Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.

View Article and Find Full Text PDF
October 2020

Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.

Int J Cancer 2020 Oct 18;147(8):2293-2302. Epub 2020 Jun 18.

Department of Hematology and Oncology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Hindenburgdamm 30, Berlin, 12203, Germany.

View Article and Find Full Text PDF
October 2020

Mutations Predict Sensitivity to Adjuvant Gemcitabine in Patients with Pancreatic Ductal Adenocarcinoma: Next-Generation Sequencing Results from the CONKO-001 Trial.

Clin Cancer Res 2020 Jul 31;26(14):3732-3739. Epub 2020 Mar 31.

Institute of Pathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

View Article and Find Full Text PDF
July 2020

Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.

Lung Cancer 2019 12 11;138:43-51. Epub 2019 Oct 11.

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Institute of Pathology, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address:

View Article and Find Full Text PDF
December 2019

Proteogenomic systems analysis identifies targeted therapy resistance mechanisms in EGFR-mutated lung cancer.

Int J Cancer 2019 02 8;144(3):545-557. Epub 2018 Nov 8.

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Pathology, Berlin, Germany.

View Article and Find Full Text PDF
February 2019

Multilayered Omics-Based Analysis of a Head and Neck Cancer Model of Cisplatin Resistance Reveals Intratumoral Heterogeneity and Treatment-Induced Clonal Selection.

Clin Cancer Res 2018 01 23;24(1):158-168. Epub 2017 Oct 23.

Charité, Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Radiooncology and Radiotherapy, Berlin, Germany.

View Article and Find Full Text PDF
January 2018

Semiconductor sequencing: how many flows do you need?

Bioinformatics 2015 Apr 4;31(8):1199-203. Epub 2014 Dec 4.

Institute of Pathology, Charité University Hospital, Charitéplatz 1, 10117 Berlin, Germany, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany and German Consortium for Translational Cancer Research (DKTK), Berlin partner site, Charitéplatz 1, 10117 Berlin, Germany Institute of Pathology, Charité University Hospital, Charitéplatz 1, 10117 Berlin, Germany, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany and German Consortium for Translational Cancer Research (DKTK), Berlin partner site, Charitéplatz 1, 10117 Berlin, Germany.

View Article and Find Full Text PDF
April 2015

Regulation of mRNA expression in drug-sensitive and drug-resistant gastric carcinoma cells is independent of YB-1 expression.

Anticancer Res 2010 Feb;30(2):693-8

Charité Campus Mitte, Institute of Pathology, Charitéplatz 1, D-10117 Berlin, Germany.

View Article and Find Full Text PDF
February 2010

Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells.

Anticancer Res 2010 Feb;30(2):629-33

Charité Campus Mitte, Institute of Pathology, D-10117 Berlin, Germany.

View Article and Find Full Text PDF
February 2010